Decentralized trials startup Curebase scraps clinical operations unit, narrows in on software

Decentralized clinical trials startup Curebase has laid off many employees as the company scraps its clinical operations business to focus on software, per a Thursday LinkedIn post from founder and CEO Tom Lemberg.

Curebase’s downsizing and narrowed ambitions come as the decentralized and hybrid clinical trials…
Click here to view original post